A detailed history of Franklin Resources Inc transactions in Insmed Inc stock. As of the latest transaction made, Franklin Resources Inc holds 2,721,389 shares of INSM stock, worth $198 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,721,389
Previous 2,718,290 0.11%
Holding current value
$198 Million
Previous $182 Million 9.08%
% of portfolio
0.06%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $192,138 - $244,851
3,099 Added 0.11%
2,721,389 $199 Million
Q2 2024

Aug 14, 2024

SELL
$22.0 - $69.71 $18.7 Million - $59.2 Million
-848,723 Reduced 23.79%
2,718,290 $182 Million
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $4.38 Million - $5.1 Million
170,286 Added 5.01%
3,567,013 $96.8 Million
Q4 2023

Feb 09, 2024

SELL
$23.42 - $31.74 $353,876 - $479,591
-15,110 Reduced 0.44%
3,396,727 $105 Million
Q3 2023

Nov 13, 2023

SELL
$19.86 - $26.93 $433,007 - $587,154
-21,803 Reduced 0.63%
3,411,837 $86.1 Million
Q2 2023

Aug 11, 2023

SELL
$16.44 - $21.1 $1.21 Million - $1.55 Million
-73,536 Reduced 2.1%
3,433,640 $72.4 Million
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $13,073 - $17,470
804 Added 0.02%
3,507,176 $59.8 Million
Q4 2022

Feb 10, 2023

SELL
$16.98 - $23.15 $103,000 - $140,427
-6,066 Reduced 0.17%
3,506,372 $70.1 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $232,749 - $314,456
11,147 Added 0.32%
3,512,438 $75.7 Million
Q2 2022

Aug 11, 2022

BUY
$17.07 - $25.71 $2.91 Million - $4.39 Million
170,607 Added 5.12%
3,501,291 $69 Million
Q1 2022

May 13, 2022

BUY
$20.42 - $28.13 $51,397 - $70,803
2,517 Added 0.08%
3,330,684 $78.3 Million
Q4 2021

Feb 11, 2022

SELL
$25.89 - $33.45 $3.1 Million - $4 Million
-119,621 Reduced 3.47%
3,328,167 $90.7 Million
Q3 2021

Nov 12, 2021

SELL
$22.46 - $29.47 $22,325 - $29,293
-994 Reduced 0.03%
3,447,788 $95 Million
Q2 2021

Aug 13, 2021

BUY
$24.17 - $36.01 $14.8 Million - $22.1 Million
614,197 Added 21.67%
3,448,782 $98.2 Million
Q1 2021

May 13, 2021

BUY
$32.28 - $44.3 $1.29 Million - $1.77 Million
39,880 Added 1.43%
2,834,585 $96.5 Million
Q4 2020

Feb 10, 2021

SELL
$31.45 - $40.54 $3.52 Million - $4.53 Million
-111,779 Reduced 3.85%
2,794,705 $93 Million
Q3 2020

Nov 12, 2020

BUY
$26.0 - $34.5 $5 Million - $6.64 Million
192,394 Added 7.09%
2,906,484 $93.4 Million
Q2 2020

Aug 13, 2020

BUY
$14.11 - $29.42 $10.2 Million - $21.3 Million
724,505 Added 36.41%
2,714,090 $72.2 Million
Q1 2020

May 13, 2020

BUY
$13.63 - $33.98 $17.6 Million - $43.8 Million
1,287,785 Added 183.5%
1,989,585 $31.9 Million
Q4 2019

Feb 12, 2020

BUY
$16.12 - $24.98 $639,964 - $991,706
39,700 Added 6.0%
701,800 $16.8 Million
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $5.65 Million - $9.41 Million
365,000 Added 122.85%
662,100 $11.7 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $6.83 Million - $9.56 Million
297,100 New
297,100 $7.61 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.85B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.